Categories
Noncommunicable disease deaths in the Americas have risen 43% since 2000, PAHO report shows
Noncommunicable disease deaths in the Americas have risen 43% since 2000, PAHO report shows
Cristina Mitchell
2 Jul 2025
Categories
Cybersecurity Vulnerabilities with Certain Patient Monitors from Contec and Epsimed: FDA Safety Communication
The FDA is raising awareness about cybersecurity vulnerabilities with Contec CMS8000 and Epsimed MN-120 patient monitors.
Categories
Early Alert: Infusion Pump Software Issue from Baxter
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Categories
Early Alert: Blood Pump Controller Issue from Abiomed
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Categories
Extended-Release Stimulants for ADHD: FDA Drug Safety Communication – FDA Requires Expanded Labeling about Weight Loss Risk in Patients Younger than 6 Years
The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations of amphetamine and methylphenidate – to warn about the risk of weight loss and other adverse reactions (side effects) in patients yo
Categories
OPS y SEGIB refuerzan su alianza para una Iberoamérica más saludable e inclusiva
PAHO and SEGIB strengthen their partnership for a healthier and more inclusive Ibero-America
Cristina Mitchell
30 Jun 2025
Categories
Suriname certified malaria-free by WHO
Suriname certified malaria-free by WHO
Cristina Mitchell
30 Jun 2025
Categories
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies
http://www.fda.gov/news-events/press-announcements/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor
Categories
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
Sandoz, Inc. (“Sandoz”) is initiating a voluntary recall of one (1) lot of Cefazolin for Injection, USP, 1 gram per vial.
Categories
Decisiones estratégicas para la salud regional marcan el cierre del 176.º Comité Ejecutivo de la OPS
Strategic Decisions for Regional Health Mark Close of PAHO’s 176th Executive Committee Meeting
Cristina Mitchell
27 Jun 2025
